Laura Fitzpatrick

Laura Fitzpatrick is a partner at Simmons Hanly Conroy in the Complex Litigation Department. Based out of the New Orleans office, her primary practice is in the area of mass torts or multidistrict litigation and complex class actions, including products liability, pharmaceutical and medical device litigation. Familiar with all phases of litigation both in and out of the courtroom, Laura has considerable federal court trial experience as a member of the bellwether trial teams for the litigation she works on. Her ability to work collaboratively with hundreds of lawyers from dozens of law firms accentuates her already notable skill set. Her recent high profile cases include serving on the lead trial teams of the In re: National Prescription Opiate Litigation, MDL 2804 (Northern District of Ohio) litigation which resulted in the first ever jury verdict against the chain pharmacy defendants, ordering CVS, Walgreens and Wal Mart to pay $650.5 million in abatement costs for their involvement in the opioid crisis in two Ohio counties as well as In re: Opioid Litigation County of Suffolk v. Purdue Pharma LP et al., culminating in the first jury verdict against opioid manufacturers and distributors, ultimately resulting in $1.7 billion in settlements. Laura and the opioid team’s efforts resulted in over $60 billion in settlements for communities throughout the country. Laura was also vital member of the trial team that secured three consecutive bellwether 10 and 9-figure verdicts on behalf of patients injured by Johnson & Johnson/Depuy’s Pinnacle metal-on-metal hip replacement in the Northern District of Texas. Laura is currently on the Plaintiff’s Executive Committee for In re: Allergan Biocell Textured Breast Implant Products Liability Litigation, MDL 2921 (District of New Jersey).